Article Details
Retrieved on: 2022-11-12 13:49:42
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
... Avdoralimab (IPH5401), a monoclonal antibody blocking C5a binding to C5aR1 that is in Phase II clinicals trials for the treatment of COVID-19, ...
Article found on: reporter.am
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here